Comerica Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-283
| Closed | -$233K | – | 490 |
|
|
2023
Q1 | $233K | Sell |
283
-2
| -0.7% | -$1.64K | 0.02% | 429 |
|
|
2022
Q4 | $206K | Buy |
+285
| New | +$206K | 0.01% | 467 |
|
|
2022
Q1 | – | Sell |
-510
| Closed | -$322K | – | 523 |
|
|
2021
Q4 | $322K | Sell |
510
-46
| -8% | -$29K | 0.02% | 406 |
|
|
2021
Q3 | $336K | Sell |
556
-163
| -23% | -$98.5K | 0.02% | 383 |
|
|
2021
Q2 | $402K | Sell |
719
-104
| -13% | -$58.1K | 0.03% | 347 |
|
|
2021
Q1 | $389K | Buy |
823
+374
| +83% | +$177K | 0.03% | 361 |
|
|
2020
Q4 | $217K | Buy |
+449
| New | +$217K | 0.02% | 457 |
|
|
2020
Q3 | – | Sell |
-1,276
| Closed | -$796K | – | 464 |
|
|
2020
Q2 | $796K | Buy |
+1,276
| New | +$796K | 0.08% | 208 |
|
|
2019
Q1 | – | Sell |
-988
| Closed | -$369K | – | 442 |
|
|
2018
Q4 | $369K | Sell |
988
-28
| -3% | -$10.5K | 0.05% | 291 |
|
|
2018
Q3 | $411K | Buy |
1,016
+27
| +3% | +$10.9K | 0.05% | 303 |
|
|
2018
Q2 | $341K | Buy |
989
+38
| +4% | +$13.1K | 0.04% | 320 |
|
|
2018
Q1 | $327K | Buy |
951
+68
| +8% | +$23.4K | 0.04% | 317 |
|
|
2017
Q4 | $332K | Buy |
883
+11
| +1% | +$4.14K | 0.04% | 317 |
|
|
2017
Q3 | $390K | Buy |
872
+211
| +32% | +$94.4K | 0.05% | 288 |
|
|
2017
Q2 | $325K | Buy |
661
+112
| +20% | +$55.1K | 0.05% | 302 |
|
|
2017
Q1 | $213K | Buy |
+549
| New | +$213K | 0.03% | 361 |
|
|
2015
Q3 | – | Sell |
-793
| Closed | -$405K | – | 301 |
|
|
2015
Q2 | $405K | Buy |
+793
| New | +$405K | 0.1% | 212 |
|